50738-62-0

Basic information

• Product Name: methyl 3-formylcyclohexane-1-carboxylate
• Synonyms: methyl 3-formylcyclohexane-1-carboxylate
• CAS NO: 50738-62-0
• Molecular Formula: C₉H₁₄O₃
• Molecular Weight: 170.20566
• Mol File: 50738-62-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
• Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly)
• CAS DataBase Reference: methyl 3-formylcyclohexane-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-formylcyclohexane-1-carboxylate(50738-62-0)
• EPA Substance Registry System: methyl 3-formylcyclohexane-1-carboxylate(50738-62-0)

Safety Data

• Hazardous Substances Data: 50738-62-0(Hazardous Substances Data)

Upstream product

• 25090-39-5 cis-1,3-cyclohexanedicarboxylic acid monoester 
• 62638-06-6 dimethyl cyclohexane-1,3-dicarboxylate 
• 3971-31-1 cyclohexane-1,3-dicarboxylic acid 
• 201424-15-9 methyl 3-(hydroxymethyl)cyclohexane-1-carboxylate 

Relevant articles and documents

Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal Activity

Mitochondrial fragmentation from defective fusion or unopposed fission contributes to many neurodegenerative diseases. Small molecule mitofusin activators reverse mitochondrial fragmentation in vitro, promising a novel therapeutic approach. The first-in-c

NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES

Disclosed herein are 5 or 8-substituted imidazo[l,5-a]pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo[l,5-a]pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8- substituted imidazo[l,5-a]pyridines that can be useful for inhibiting indoleamine 2,3- dioxygenase and/or tryptophane 2,3-dioxygenase and for treating diseases or disorders mediated thereby.

Pyridine derivatives

Pyridine compounds of general formula: wherein —R1represents in which R11is hydrogen, C1-6alkyl, halogen, hydroxy, C1-12alkoxy, nitro, amino, C1-6alkylsulfonylamino, C1-6alkoxycarbonyl, C1-6alkylamino, di(C1-6alkyl)amino, C1-6alkanoylamino, phenyl C1-6alkylamino, phenylsulfonylamino, or —O—(CH2)n—R111; R2represents hydrogen or halogen; R3represents hydrogen, —CR31R32R33, or —NR34R35; R4is hydrogen, carbamoyl, CN, carboxyl, etc.; R5is amino, C1-6alkylamino, di C1-6alkylamino, etc. or salt thereof. The compound has an excellent anti-inflammatory activity, and other biological activity.